An experimental drug tamps down the expression of MECP2, the gene that’s duplicated in an autism-related condition, and restores typical behavior in mice.

The findings suggest that the therapy might also work for children with MECP2 duplication syndrome, which is characterized by autism, movement problems and seizures.

View Full Article

You need to login or register to bookmark/favorite this content.